文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人心肌类器官用于心肌梗死和药物心脏毒性的建模。

Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

机构信息

Bioengineering Department, Clemson University, Clemson, SC, USA.

Immunology Translational Sciences, Janssen Research and Development, LLC, Spring House, PA, USA.

出版信息

Nat Biomed Eng. 2020 Apr;4(4):446-462. doi: 10.1038/s41551-020-0539-4. Epub 2020 Apr 13.


DOI:10.1038/s41551-020-0539-4
PMID:32284552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7422941/
Abstract

Environmental factors are the largest contributors to cardiovascular disease. Here we show that cardiac organoids that incorporate an oxygen-diffusion gradient and that are stimulated with the neurotransmitter noradrenaline model the structure of the human heart after myocardial infarction (by mimicking the infarcted, border and remote zones), and recapitulate hallmarks of myocardial infarction (in particular, pathological metabolic shifts, fibrosis and calcium handling) at the transcriptomic, structural and functional levels. We also show that the organoids can model hypoxia-enhanced doxorubicin cardiotoxicity. Human organoids that model diseases with non-genetic pathological factors could help with drug screening and development.

摘要

环境因素是心血管疾病的最大诱因。在这里,我们展示了一种包含氧扩散梯度的心脏类器官,它受到神经递质去甲肾上腺素的刺激,模拟了心肌梗死后人类心脏的结构(通过模拟梗死、边缘和远程区域),并在转录组、结构和功能水平上再现了心肌梗死的特征(特别是病理性代谢转变、纤维化和钙处理)。我们还表明,类器官可以模拟缺氧增强的阿霉素心脏毒性。能够模拟具有非遗传病理因素的疾病的人类类器官可能有助于药物筛选和开发。

相似文献

[1]
Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

Nat Biomed Eng. 2020-4-13

[2]
Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids.

Cell Death Dis. 2024-5-1

[3]
Assessment of doxorubicin toxicity using human cardiac organoids: A novel model for evaluating drug cardiotoxicity.

Chem Biol Interact. 2023-12-1

[4]
Q&A: Hans Clevers. Banking on organoids.

Nature. 2015-5-14

[5]
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening.

Nat Cell Biol. 2019-8-1

[6]
Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice.

Circulation. 2010-1-25

[7]
Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.

Curr Med Chem. 2024

[8]
Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease.

Sci Rep. 2021-3-9

[9]
Concise Review: Precision Matchmaking: Induced Pluripotent Stem Cells Meet Cardio-Oncology.

Stem Cells Transl Med. 2019-4-24

[10]
Cardioprotective effect of boswellic acids against doxorubicin induced myocardial infarction in rats.

Pak J Pharm Sci. 2021-1

引用本文的文献

[1]
Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential.

J Cardiovasc Dev Dis. 2025-7-26

[2]
Human retinal organoids for modelling dry age-related macular degeneration and screening drugs.

Genes Dis. 2025-3-7

[3]
Innovative strategies for bone organoid: Synergistic application and exploration of advanced technologies.

J Orthop Translat. 2025-8-14

[4]
From niche to organoid: Engineering bone tissues through microenvironmental insights.

J Tissue Eng. 2025-7-29

[5]
Integrative approaches in cardiac tissue engineering: Bridging cellular complexity to create accurate physiological models.

iScience. 2025-6-25

[6]
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.

Pharmacol Rev. 2025-6-26

[7]
Advanced Cardiac Organoid Model for Studying Doxorubicin-Induced Cardiotoxicity.

bioRxiv. 2025-5-8

[8]
Phenotypic screening uncovered anti-myocardial fibrosis candidates using a novel 3D myocardial tissue under hypoxia.

Acta Pharm Sin B. 2025-6

[9]
A versatile and open source design for one and two photon light sheet microscopy.

Sci Rep. 2025-7-3

[10]
Rational design matrix materials for organoid development and application in biomedicine.

Regen Biomater. 2025-5-14

本文引用的文献

[1]
Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure.

ACS Biomater Sci Eng. 2017-9-11

[2]
Shortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue.

ACS Biomater Sci Eng. 2017-9-11

[3]
Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload.

Nat Biomed Eng. 2018-9-10

[4]
Human Tissue-Engineered Model of Myocardial Ischemia-Reperfusion Injury.

Tissue Eng Part A. 2018-11-20

[5]
The interstitium in cardiac repair: role of the immune-stromal cell interplay.

Nat Rev Cardiol. 2018-10

[6]
Emerging Role of Precision Medicine in Cardiovascular Disease.

Circ Res. 2018-4-27

[7]
Organoids in cancer research.

Nat Rev Cancer. 2018-7

[8]
A three-dimensional in vitro dynamic micro-tissue model of cardiac scar formation.

Integr Biol (Camb). 2018-3-1

[9]
A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure.

NPJ Syst Biol Appl. 2018-2-24

[10]
Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes.

Stem Cell Reports. 2018-3-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索